Advertisement

The Multistage Concept of Carcinogenesis

  • Carl Peraino
  • Carol A. Jones

Abstract

The recognition of carcinogenesis as a complex multievent process has developed from evidence gained over the past 50 years of research in experimental oncology demonstrating that tumors can be induced in high yield by the combined administration of agents that may have little or no carcinogenic activity when given singly. Three major types of tumorigenic enhancement may be defined on the basis of the types of inducing agents used and of the temporal relationships of their administration:
  1. 1.

    Syncarcinogenesis: Synergistic enhancement of tumor formation by simultaneous1 or sequential treatment2 with two carcinogens that separately may have relatively little carcinogenic activity

     
  2. 2.

    Cocarcinogenesis: Enhancement of tumor formation by simultaneous administration of a carcinogen and an additional agent (cocarcinogen) that has no intrinsic carcinogenic activity but facilitates carcinogen action3–8

     
  3. 3.

    Two-stage, or initiation-promotion carcinogenesis: Enhancement of tumor formation by the sequential administration of a carcinogen (initiator) and an additional agent (promoter) that has no intrinsic carcinogenic activity but facilitates expression of prior carcinogen-induced cryptic cellular changes.3 In this context, an initiating agent is exemplified by a subcarcinogenic dose of carcinogen, i.e., one that will not elicit neoplasms within the life span of an animal but that will produce an irreversible fundamental change (i.e., mutation) in the cells of a target organ or tissue so as to predispose them to neoplastic transformation when they are further subjected to an appropriate tumor promoting stimulus. A tumor promoter, exemplified by certain plant products, hormones, and xenobiotics acts to affect gene expression and to stimulate a hyperplastic expansion of the initiated cell population. This process ultimately results in the development of persistent precancerous nodules, papillomas, or polyps within the target tissue or organ. Some of these lesions can then undergo progression to malignant neoplasms (see Chapter 10).

     

Keywords

Phorbol Ester Tumor Promotion Mouse Skin Metabolic Cooperation Human Endometrial Stromal Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations used in this chapter

AAF

2-acetylaminofluorene

BHT

butylated hydroxytoluene

DAG

diacylglycerol

DDT

dichlorodiphenyltrichloroethane

DMN

dimethylnitrosamine

HGPRT

hypoxanthineguanine phosphoribosyltransferase

MNNG

N-methyl-N’-nitro-N-nitrosoguanidine

PCB

polychlorinated bi-phenyls

PKC

protein kinase C

TCDD

2,3,7,8-tetrachlorodibenzo-p-dioxin

TPA

12-O-tetradecanoylphorbol 13-acetate

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mori, H., Kunyasu, T., Sugie, S., Shima, H., and Takahashi, T., 1985, Syncarcinogenic effects of methyl methanesulfonate with methylazoxymethanol acetate in rat small intestine and liver, Carcinogenesis 6: 1529–1531.PubMedCrossRefGoogle Scholar
  2. 2.
    Michejda, C. J., Kroeger-Koepke, M. B., and Kovatch, R. M., 1986, Carcinogenic effects of sequential administration of two nitrosamines in Fischer 344 rats, Cancer Res. 46: 2252–2256.PubMedGoogle Scholar
  3. 3.
    Boutwell, R. K., 1964, Some biological aspects of skin carcinogenesis, in: Progress in Experimental Tumor Research, Vol. 4 ( F. Homburger, ed.), pp. 207–250, S. Karger, New York.Google Scholar
  4. 4.
    Berenblum, I., 1969, A re-evaluation of the concept of cocarcinogenesis, in: Progress in Experimental Tumor Research, Vol. 11 ( F. Homburger, ed.), pp. 21–30, S. Karger, New York.Google Scholar
  5. 5.
    Van Duuren, B. L., and Goldschmidt, B. M., 1976, Cocarcinogenic and tumor-promoting agents in tobacco carcinogenesis, J. Natl. Cancer Inst. 56: 1237–1242.PubMedGoogle Scholar
  6. 6.
    Sivak, A., 1979, Cocarcinogenesis, Biochim. Biophys. Acta 560: 67–89.PubMedGoogle Scholar
  7. 7.
    Wilpart, M., and Robertfroid, M., 1986, Effects of secondary biliary acids on the mutagenicity of Nmethyl-N’-nitro-N-nitrosoguanidine, 2-acetylaminofluorene and 2-nitrofluorene towards Salmonella typhimurium strains, Carcinogenesis 7: 703–706.PubMedCrossRefGoogle Scholar
  8. 8.
    Deml, E., and Oesterle, D., 1986, Enhancing effect of co-administration of polychlorinated biphenyls and diethylnitrosamine on enzyme-altered islands induced by diethylnitrosamine in rat liver, Carcinogenesis 7: 1697–1700.PubMedCrossRefGoogle Scholar
  9. 9.
    Potter, M., 1963, Percival Pott’s contributions to cancer research, in: Conference on Biology of Cutaneous Cancer, NCI Monograph No. 10 ( F. Urbach, ed.), pp. 1–13, National Cancer Institute, Washington, D.C.Google Scholar
  10. 10.
    Shimkin, M. B., and Triolo, V. A., 1969, History of chemical carcinogenesis: Some prospective remarks, in: Progress in Experimental Tumor Research, Vol. 11 ( F. Homburger, ed.), pp. 1–20, S. Karger, New York.Google Scholar
  11. 11.
    Yamigawa, K., and Ichikawa, K., 1918, Experimental study of the pathogenesis of carcinoma, J. Cancer Res. 3: 1–21.Google Scholar
  12. 12.
    Deelman, H. T., 1927, The part played by injury and repair in the development of cancer; with remarks on the growth of experimental cancers, Br. Med. J. 1: 872.PubMedCrossRefGoogle Scholar
  13. 13.
    Twort, J. M., and Twort, C. C., 1939, Comparative activity of some carcinogenic hydrocarbons, Am. J. Cancer 35: 80–85.Google Scholar
  14. 14.
    Twort, C. C., and Ing, H. R., 1928, Untersuchungen uber Krebserzeugende agenzien, Z. Krebsforsch. 27: 309–351.Google Scholar
  15. 15.
    Rous, P., and Kidd, J. G., 1941, Conditional neoplasms and subthreshold neoplastic states: a study of the tar tumors of rabbits, J. Exp. Med. 73: 365–390.PubMedCrossRefGoogle Scholar
  16. 16.
    Friedewald, W. F., and Rous, P., 1944, The initiating and promoting elements in tumor production: An analysis of the effects of tar, benzpyrene, and methylcholanthrene on rabbit skin, J. Exp. Med. 80: 101–125.PubMedCrossRefGoogle Scholar
  17. 17.
    Berenblum, I., 1941, The cocarcinogenic action of croton resin, Cancer Res. 1: 44–48.Google Scholar
  18. 18.
    Berenblum, I., and Shubik, P., 1947, A new quantitative approach to the study of stages of chemical carcinogenesis in the mouse’s skin, Br. J. Cancer 1: 383–391.PubMedCrossRefGoogle Scholar
  19. 19.
    Mottram, J. C., 1944, A developing factor in experimental blastogenesis, J. Pathol. 56: 181–187.CrossRefGoogle Scholar
  20. 20.
    Berenblum, I., and Shubik, P., 1949, The persistence of latent tumor cells induced in the mouse’s skin by a single application of 9,10-dimethyl-1,2-benzanthracene, Br. J. Cancer 3: 384–386.PubMedCrossRefGoogle Scholar
  21. 21.
    Berenblum, I., and Haran, N., 1955, The significance of the sequence of initiating and promoting actions in the process of skin carcinogenesis in the mouse, Br. J. Cancer 9: 268–271.PubMedCrossRefGoogle Scholar
  22. 22.
    Roe, F. J. C., 1959, The effect of applying croton oil before a single application of 9,10-dimethyl-1,2benzanthracene, Br. J. Cancer 13: 87–91.PubMedCrossRefGoogle Scholar
  23. 23.
    Van Duuren, B. L., 1965, The tumor enhancing principles of Crown tiglium L., Cancer Res. 25: 1871–1875.PubMedGoogle Scholar
  24. 24.
    Hecker, E., 1971, Isolation and characterization of the cocarcinogenic principles from croton oil, in: Methods in Cancer Research, Vol. 6 ( H. Busch, ed.), pp. 439–484, Academic, New York.Google Scholar
  25. 25.
    Furstenberger, G., Berry, D. L., Sorg, B., and Marks, F., 1981, Skin tumor promotion by phorbol esters is a two-stage process, Proc. Natl. Acad. Sci. USA 78: 7722–7726.PubMedCrossRefGoogle Scholar
  26. 26.
    Furstenberger, G., Sorg, B.. and Marks, F., 1983, Tumor promotion by phorbol esters in mouse skin: Evidence for a memory effect, Science 220: 89–91.PubMedCrossRefGoogle Scholar
  27. 27.
    Slaga, T. J., 1984, Multistage skin tumor promotion and specificity of inhibition, in: Mechanisms of Tumor Promotion, Vol. II: Tumor Promotion and Skin Carcinogenesis ( T. J. Slaga, ed.), pp. 189–196, CRC Press, Boca Raton, Florida.Google Scholar
  28. 28.
    Furstenberger, G., Kinzel, V., Schwarz, M., and Marks, F., 1985, Partial inversion of the initiation-promotion sequence of multistage tumorigenesis in the skin of NMRI mice, Science 230: 76–78.PubMedCrossRefGoogle Scholar
  29. 29.
    Kinzel, V., Furstenberger, G., Loehrke, H., and Marks, F., 1986, Three-stage tumorigenesis in mouse skin: DNA synthesis as a prerequisite for the conversion stage induced by TPA prior to initiation, Carcinogenesis 7: 779–782.PubMedCrossRefGoogle Scholar
  30. 30.
    Yamasaki, H., Aguelon-Pegouries, A.-M., Enomoto, T., Martel, N., Furstenberger, G., and Marks, F., 1985, Comparative effects of a complete tumor promoter, TPA, and a second-stage tumor promoter, RPA, on intercellular communication, cell differentiation and cell transformation. Carcinogenesis 6: 1173–1179.PubMedCrossRefGoogle Scholar
  31. 31.
    Bryan, G. T., and Springberg, P. D., 1966, Role of the vehicle in the genesis of bladder carcinomas in mice by the pellet implantation technic, Cancer Res. 26: 105–109.PubMedGoogle Scholar
  32. 32.
    Cohen, S. M., Murasaki, G., Ellwein, L. B., and Greenfield, R. E., 1983, Tumor promotion in bladder carcinogenesis, in: Mechanisms of Tumor Promotion, Vol. 1: Tumor Promotion in Internal Organs ( T. J. Slaga, ed.), pp. 131–149, CRC Press, Boca Raton, Florida.Google Scholar
  33. 33.
    Hicks, R. M., Wakefield, J., and Chowaniec, J., 1975, Evaluation of a new model to detect bladder carcinogens or cocarcinogens: Results obtained with saccharine, cyclamate, and cyclophosphamide, Chem. Biol. Interact. 11: 225–233.PubMedCrossRefGoogle Scholar
  34. 34.
    Peraino, C., Fry, R. J. M., and Staffeldt, E., 1971, Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene, Cancer Res. 31: 1506–1512.PubMedGoogle Scholar
  35. 35.
    Peraino, C., Fry, R. J. M., Staffeldt, E., and Kisieleski, W. E., 1973, Effects of varying the exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat, Cancer Res. 33: 2701–2705.PubMedGoogle Scholar
  36. 36.
    Peraino, C., Fry, R. J. M., and Staffeldt, E., 1977, Effects of varying the onset and duration of exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis, Cancer Res. 37: 3623–3627.PubMedGoogle Scholar
  37. 37.
    Peraino, C., Richards, W. L., and Stevens, F. J., 1983, Multistage hepatocarcinogenesis, in: Mechanisms of Tumor Promotion, Vol. 1: Tumor Promotion in Internal Organs ( T. J. Slaga, ed.), pp. 1–53, CRC Press, Boca Raton, Florida.Google Scholar
  38. 38.
    Steele, V. E., and Nettesheim, P., 1983, Tumor promotion in respiratory tract carcinogenesis, in: Mechanisms of Tumor Promotion, Vol. 1: Tumor Promotion in Internal Organs ( T. J. Slaga, ed.), pp. 91–105, CRC Press, Boca Raton, Florida.Google Scholar
  39. 39.
    Armuth, V., and Berenblum, I., 1972, Systemic promoting action of phorbol in liver and lung carcinogenesis in AKR mice, Cancer Res. 32: 2259–2262.PubMedGoogle Scholar
  40. 40.
    Witschi, H. P., Williamson, D., and Lock, S., 1977, Enhancement of urethan tumorigenesis in mouse lung by butylated hydroxytoluene, J. Natl. Cancer Inst. 58: 301–305.PubMedGoogle Scholar
  41. 41.
    Inayama, Y., 1986, Promoting action of glycerol in pulmonary tumorigenesis model using a single administration of 4-nitroquinoline 1-oxide in mice, Jpn. J. Cancer Res. 77: 345–350.PubMedGoogle Scholar
  42. 42.
    Topping, D. C., and Nettesheim, P., 1980, Two stage carcinogenesis studies with asbestos fibers in Fischer 344 rats, J. Natl. Cancer Inst. 65: 627–630.PubMedGoogle Scholar
  43. 43.
    Topping, D. C., and Nettesheim, P., 1980, Promotion-like enhancement of tracheal carcinogenesis in rats by 12-O-tetradecanoyl-phorbol-13-acetate, Cancer Res. 40: 4352–4355.PubMedGoogle Scholar
  44. 44.
    Marchok, A. C., Cone, V., and Nettesheim, P., 1975, Induction of squamous metaplasia in tracheal organ cultures, Lab. Invest. 33: 451–460.PubMedGoogle Scholar
  45. 45.
    Steele, V. E., Marchok, A. C., and Nettesheim, P., 1980, Enhancement of carcinogenesis in cultured respiratory tract epithelium by 12-O-tetradecanoylphorbol-13-acetate, Int. J. Cancer 26: 343–348.PubMedCrossRefGoogle Scholar
  46. 46.
    Steele, V. E., Marchok, A. C., and Nettesheim, P., 1978, Establishment of epithelial cell lines following exposure of cultured tracheal epithelium to 12-O-tetradecanoylphorbol-13-acetate, Cancer Res. 38: 3563–3565.PubMedGoogle Scholar
  47. 47.
    Steele, V. E., and Beeman, D. K., 1981, Relationships of increased growth capacity and tumor promotion in cultured rat tracheal cells, In Vitro 17: 202–203.Google Scholar
  48. 48.
    Reddy, B. S., 1983, Tumor promotion in colon carcinogenesis, in: Mechanisms of Tumor Promotion, Vol. I: Tumor Promotion in Internal Organs ( T. J. Slaga, ed.), pp. 107–129, CRC Press, Boca Raton, Florida.Google Scholar
  49. 49.
    Watanabe, K., Reddy, B. S., Wong, C. Q., and Weisburger, J. H., 1978, Effect of dietary undegraded carageenin on colon carcinogenesis in F344 rats treated with azoxymethane or methylnitrosourea, Cancer Res. 38: 4427–4430.PubMedGoogle Scholar
  50. 50.
    Pollard, M. S., and Luckert, P. H., 1979, Promotional effect of sodium barbiturate on intestinal tumors induced in rats by dimethyl hydrazine, J. Natl. Cancer Inst. 63: 1089–1092.PubMedGoogle Scholar
  51. 51.
    Lindenschmidt, R. C., Tryka, A. F., Goad, M. E., and Witschi, H. P., 1986, The effects of dietary butylated hydroxytoluene on liver and colon tumor development in mice, Toxicology 38: 151–160.PubMedCrossRefGoogle Scholar
  52. 52.
    Nigro, N. D., Singh, D. V., Campbell, R. L., and Pak, M. S., 1975, Effect of dietary beef fat on intestinal tumor formation by azoxymethane in rats, J. Natl. Cancer Inst. 54: 439–442.PubMedGoogle Scholar
  53. 53.
    Reddy, B. S., Watanabe, K., and Weisburger, J. H., 1977, Effect of high fat diet on colon carcinogenesis in F344 rats treated with 1,2-dimethylhydrazine, methylazoxymethanol acetate, or methylnitrosourea, Cancer Res. 37: 4156–4159.PubMedGoogle Scholar
  54. 54.
    Chomchai, C., Bhadarachari, N., and Nigro, N. D., 1974, The effect of bile on the induction of experimental intestinal tumors in rats, Dis. Colon Rectum 17: 310–312.PubMedCrossRefGoogle Scholar
  55. 55.
    Narisawa, T., Magadia, N. E., Weisburger, J. H., and Wynder, E. L., 1974, Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N’-nitro-N-nitrosoguanidine in rats, J. Natl. Cancer Inst. 53: 1093–1097.PubMedGoogle Scholar
  56. 56.
    Reddy, B. S., and Watanabe, K., 1979, Effect of cholesterol metabolites and promoting effect of lithocholic acid in colon carcinogenesis in germ-free and conventional F344 rats, Cancer Res. 39: 1521–1524.PubMedGoogle Scholar
  57. 57.
    Cohen, B. I., Raicht, R. F., Deschner, E. E., Takahashi, M., Sarwal, A. N., and Fazzini, E, 1980, Effect of cholic acid feeding on N-methyl-N-nitrosourea-induced colon tumors and cell kinetics in rats, J. Natl. Cancer Inst. 61: 573–578.Google Scholar
  58. 58.
    Reddy, B. S., and Maeura, Y., 1984, Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: Influence of amount and source of dietary fat, J. Natl. Cancer Inst. 72: 745–750.PubMedGoogle Scholar
  59. 59.
    Reddy, B. S., Tanaka, T., and Simi, B., 1985, Effect of different levels of dietary trans fat or corn oil on azoxymethane-induced colon carcinogenesis in F344 rats, J. Natl. Cancer Inst. 75: 791–798.PubMedGoogle Scholar
  60. 60.
    Bull, A. W., Nigro, N. D., Golembieski, W. A., Crissman, J. D., and Marnett, L. J., 1984, In vivo stimulation of DNA synthesis and induction of ornithine decarboxylase in rat colon by fatty acid hydro-peroxides, autoxidation products of unsaturated fatty acids, Cancer Res. 44: 4924–4928.PubMedGoogle Scholar
  61. 61.
    Bull, A. D., Marnett, L. J., Dawe, E. J., and Nigro, N. D., 1983, Stimulation of deoxythymidine incorporation in the colon of rats treated intrarectally with bile acids and fats, Carcinogenesis 4: 207–210.PubMedCrossRefGoogle Scholar
  62. 62.
    Rozhin, J., Wilson, P. S., Bull, A. W., and Nigro, N. D., Ornithine decarboxylase activity in the rat and human colon, Cancer Res. 44: 3226–3230.Google Scholar
  63. 63.
    Kaibara, N., Yurugi, E., and Koga, S., 1984, Promoting effect of bile acids on the chemical transformation of C3H/10T1/2 fibroblasts in vitro, Cancer Res. 44: 5482–5485.PubMedGoogle Scholar
  64. 64.
    Wynder, E. L., 1984, Nutrition, diet, and cancer, an evaluation, Curr. Concepts Nutr. 13: 171–193.PubMedGoogle Scholar
  65. 65.
    Moore, D. H., Moore, D. H. II, and Moore, C. T., 1983, Breast carcinoma etiological factors, Adv. Cancer Res. 40: 189–253.PubMedCrossRefGoogle Scholar
  66. 66.
    Abraham, S., Faulkin, L. J., Hillyard, L. A., and Mitchell, D. J., 1981, Effect of dietary fat on tumorigenesis in the mouse mammary gland, J. Natl. Cancer Inst. 72: 1421–1429.Google Scholar
  67. 67.
    Gabor, H., Hillyard, L. A., and Abraham, S., 1985, Effect of dietary fat on growth kinetics of transplantable mammary adenocarcinoma in BALB/c mice, J. Natl. Cancer Inst. 74: 1299–1305.PubMedGoogle Scholar
  68. 68.
    Hopkins, G. J., Hard, G. C., and West, C. E., 1978, Carcinogenesis induced by 7,12-dimethylbenz(a)anthracene in C3H-A(vy)fB mice: Influence of different dietary fats, J. Natl. Cancer Inst. 60: 849–853.PubMedGoogle Scholar
  69. 69.
    Hopkins, G. J., and West, C. E., 1977, Effect of dietary polyunsaturated fat on the growth of a transplantable adenocarcinoma in C3HA(vy)fB mice, J. Natl. Cancer Inst. 58: 753–756.PubMedGoogle Scholar
  70. 70.
    Lane, H. W., Butel, J. S., Howard, C., Shepherd, F., Halligan, R., and Medina, D., 1985, The role of high levels of dietary fat in 7,12-dimethylbenzanthracene-induced mouse mammary tumorigenesis: Lack of an effect on lipid peroxidation, Carcinogenesis 6: 403–407.PubMedCrossRefGoogle Scholar
  71. 71.
    Rao, G. A., and Abraham, S., 1976, Enhanced growth rate of transplanted mammary adenocarcinoma induced in C3H mice by dietary linoleate, J. Natl. Cancer Inst. 56: 431–432.PubMedGoogle Scholar
  72. 72.
    Welsch, C. W., and Aylsworth, C. F., 1983, Enhancement of murine mammary tumorigenesis by feeding high levels of dietary fat: A hormonal mechanism, J. Natl. Cancer Inst. 70: 215–221.PubMedGoogle Scholar
  73. 73.
    Welsch, C. W., 1985, Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: A review and tribute to Charles Brenton Huggins, Cancer Res. 45: 3415–3443.PubMedGoogle Scholar
  74. 74.
    Hopkins, G. J., and Carroll, K. K., 1979, Relationship between amount and type of dietary fat in promotion of mammary carcinogenesis induced by 7,12-dimethylbenz(a)anthracene, J. Natl. Cancer Inst. 62: 1009–1012.PubMedGoogle Scholar
  75. 75.
    Hiasa, Y., Kitahori, Y., Oshima, M., Fujita, T., Yuasa, T., Konishi, N., and Miyashiro, A., 1982, Promoting effects of phenobarbital and barbital on development of thyroid tumors in rats treated with Nbis(2-hydroxypropyl)nitrosamine, Carcinogenesis 3: 1187–1190.Google Scholar
  76. 76.
    Tsuda, H., Fukushima, S., Imaida, K., Kurata, Y., and Ito, N., 1983, Organ-specific promoting effects of phenobarbital and saccharin in induction of thyroid, liver, and urinary bladder tumors in rats after initiation with N-nitrosomethylurea, Cancer Res. 43: 3292–3296.PubMedGoogle Scholar
  77. 77.
    Diwan, B. A., Palmer, A. E., Oshima, M., and Rice, J. M., 1985, N-nitroso-N-methylurea initiation in multiple tissues for organ-specific tumor promotion in rats by phenobarbital, J. Natl. Cancer Inst. 75: 1099–1105.PubMedGoogle Scholar
  78. 78.
    Roebuck, B. D., Longnecker, D. S., and Yager, J. D., Jr., 1983, Initiation and promotion in pancreatic carcinogenesis, in: Mechanisms of Tumor Promotion, Vol. 1: Tumor Promotion in Internal Organs ( T. J. Slaga, ed.), pp. 151–171, CRC Press, Boca Raton, Florida.Google Scholar
  79. 79.
    Barrett, J. C., and Elmore, E., 1985, Comparison of carcinogenesis and mutagenesis of mammalian cells in culture, in: Mechanisms and Toxicity of Chemical Carcinogens and Mutagens ( W. G. Flamm and R. J. Lorentzen, eds.), pp. 171–206, Princeton Publishing Co., Princeton, New Jersey.Google Scholar
  80. 80.
    Berwald, Y., and Sachs, L., 1965, In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons, J. Natl. Cancer Inst. 35: 641–661.PubMedGoogle Scholar
  81. 81.
    Kakunaga, T., 1973, A quantitative system for assay of malignant transformation by chemical carcinogens using a clone derived from Balb/3T3, Int. J. Cancer 12: 463–473.PubMedCrossRefGoogle Scholar
  82. 82.
    Marchok, A. C., Rhoton, J. C., and Nettersheim, P., 1978, In vitro development of oncogenicity in cell lines established from tracheal epithelium pre-exposed in vivo to 7,12-dimethylbenz(a)anthracene, Cancer Res. 38: 2030–2037.PubMedGoogle Scholar
  83. 83.
    Heidelberger, C., Freeman, A. E., Pienta, R. J., Sivak, A., Bertram, J. S., Casto, B. C., Dunkel, V. C., Francis, M. C., Kakunaga, T., Little, J. B., and Schechtman, L. M., 1983, Cell transformation by chemical agents: A review and analysis of the literature, Mutat. Res. 114: 283–385.PubMedGoogle Scholar
  84. 84.
    Barrett, J. C., and Thomassen, D. G., 1985, Use of quantitative cell transformation assays in risk estimation, in: Methods for Estimating Risk of Chemical Injury: Human and Nonhuman Biota and Ecosystems ( V. B. Vouk, G. C. Butler, D. G. Hoel, and D. B. Peakall, eds.), pp. 201–234, Wiley, New York.Google Scholar
  85. 85.
    Lasne, C., Gentil, A., and Chouroulinkov, I., 1974, Two-stage malignant transformation of rat fibroblasts in tissue culture, Nature (Lond.) 274: 490–491.CrossRefGoogle Scholar
  86. 86.
    Mondal, S., Brankow, D. W., and Heidelberger, C., 1976, Two-stage chemical oncogenesis in cultures of C3H 10T1/2 cells, Cancer Res. 36: 2254–2260.PubMedGoogle Scholar
  87. 87.
    Sivak, A., and Van Duuren, B. L., 1970, A cell culture system for the assessment of tumor-promoting activity, J. Natl. Cancer Inst. 44: 1091–1097.PubMedGoogle Scholar
  88. 88.
    Boone, C. S., and Jacobs, J. B., 1976, Sarcomas routinely produced from putatively nontumorigenic Balb/3T3 and C3H 10T1/2 cells by subcutaneous inoculation attached to plastic platelets, J. Supramol. Struct. 5: 131–137.PubMedCrossRefGoogle Scholar
  89. 89.
    Reznikoff, C. A., Bertram, J. S., Brankow, D. W., and Heidelberger, C., 1973, Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division, Cancer Res. 33: 3239–3249.PubMedGoogle Scholar
  90. 90.
    Kennedy, A. R., 1984, Promotion and other interactions between agents in the induction of transformation in vitro in fibroblast-like cell culture systems, in: Mechanisms of Tumor Promotion, Vol. 3: Tumor Promotion and Carcinogenesis In Vitro ( T. J. Slaga, ed.), pp. 13–55, CRC Press, Boca Raton, Florida.Google Scholar
  91. 91.
    DiPaolo, J. A., Nelson, R. L., and Donovan, P. J., 1969, Sarcoma-producing cell lines derived from clones transformed in vitro by benzo(a)pyrene, Science 165: 917–918.PubMedCrossRefGoogle Scholar
  92. 92.
    Popescu, N. C., Amsbaugh, S. C., and DiPaolo, J. A., 1980, Enhancement of N-methyl-N’-nitro-Nnitrosoguanidine transformation of Syrian hamster cells by a phorbol diester is independent of sister chromatid exchanges and chromosome aberrations, Proc. Natl. Acad. Sci. USA 77: 7282–7286.PubMedCrossRefGoogle Scholar
  93. 93.
    Rivedal, E., and Sanner, T., 1982, Promotional effect of different phorbol esters on morphological transformation of hamster embryo cells, Cancer Lett. 17: 1–8.PubMedCrossRefGoogle Scholar
  94. 94.
    Jones, C. A., Callaham, M. C., and Huberman, E., 1984, Enhancement of chemical-carcinogen-induced cell transformation in hamster embryo cells by la,25-dihydroxycholecalciferol, the biologically active metabolite of vitamin D3, Carcinogenesis 5: 1155–1159.PubMedCrossRefGoogle Scholar
  95. 95.
    DiPaolo, J. A., Demarinis, A. J., Evans, C. H., and Doniger, J., 1981, Expression of initiated and promoted stages of irradiation carcinogenesis in vitro, Cancer Lett. 14: 243–249.PubMedCrossRefGoogle Scholar
  96. 96.
    Kennedy, A. R., Mondai, S., Heidelberger, C., and Little, J. B., 1978, Enhancement of x-ray transformation by phorbol 12-myristate 13-acetate in a cloned line of C3H mouse embryo cells, Cancer Res. 38: 439–443.PubMedGoogle Scholar
  97. 97.
    Kennedy, A. R., and Little, J. B., 1980, Investigations of the mechanisms for enhancement of radiation transformation in vitro by 12-O-tetradecanoylphorbol-13-acetate, Carcinogenesis 1: 1039–1047.PubMedCrossRefGoogle Scholar
  98. 98.
    Mordan, L. J., Markner, J. E., and Bertram, J. S., 1983, Quantitative neoplastic transformation of C3H/10T1/2 cells: Dependence on colony size of initiated cells at confluence, Cancer Res. 43: 4062–4067.PubMedGoogle Scholar
  99. 99.
    Dorman, B. H., Siegfried, J. M., and Kaufman, D. G., 1983, Alterations of human endometrial stromal cells produced by N-methyl-N’-nitro-nitrosoguanidine, Cancer Res. 43: 3348–3357.PubMedGoogle Scholar
  100. 100.
    Siegfried, J. M., Nelson, K. G., Martin, J. L., and Kaufman, D. G., 1984, Promotional effect of diethylstilbestrol on human endometrial stromal cells pretreated with a direct acting carcinogen, Carcinogenesis 5: 641–646.PubMedCrossRefGoogle Scholar
  101. 101.
    Siegfried, J. M., Nelson, K. G., and Kaufman, D. G., 1985, Promotion-like enhancement of transformed phenotypes in human endometrial stromal cells, in: Carcinogenesis: A Comprehensive Survey, Vol. 8 ( M. J. Mass, J. G. Kaufman, J. M. Siegfried, V. E. Steele, and S. Nesnow, eds.), pp. 279–292, Raven, New York.Google Scholar
  102. 102.
    Kitagawa, T., Watanabe, R., Kayano, T., and Sugano, H., 1980, In vitro carcinogenesis of hepatocytes obtained from acetylaminofluorene-treated rat liver and promotion of their growth by phenobarbital, Gann 71: 747–754.PubMedGoogle Scholar
  103. 103.
    Kayano, T., Nomura, K., Mino, O., and Kitagawa, T., 1982, Failure of phorbol ester TPA to promote growth of in vivo-initiated rat hepatocytes transferred into a culture system, Gann 73: 354–357.PubMedGoogle Scholar
  104. 104.
    Hennings, H., Michael, D., Cheng, C., Steinert, P., Holbrook, K., and Yuspa, S. H., 1980, Calcium regulation of growth and differentiation of mouse epidermal cells in culture, Cell 19: 245–254.PubMedCrossRefGoogle Scholar
  105. 105.
    Kulesz-Martin, M. F., Koehler, B., Hennings, H., and Yuspa, S. H., 1980, Quantitative assay for carcinogen altered differentiation in mouse epidermal cells, Carcinogenesis 1: 995–1006.PubMedCrossRefGoogle Scholar
  106. 106.
    Yuspa, S. H., 1984, Tumor promotion in epidermal cells in culture, in: Mechanisms of Tumor Promotion, Vol. 3: Tumor Promotion and Carcinogenesis In Vitro ( T. J. Slaga, ed.), pp. 1–11, CRC Press, Boca Raton, Florida.Google Scholar
  107. 107.
    Yuspa, S. H., Ben, T., Hennings, H., and Lichti, U., 1982, Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate, Cancer Res. 42: 2344–2349.PubMedGoogle Scholar
  108. 108.
    Yuspa, S. H., and Morgan, D. L., 1981, Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis, Nature (Lond.) 293: 72–74.CrossRefGoogle Scholar
  109. 109.
    Reiners, J. J., and Slaga, T. J., 1983, Effects of tumor promoters on the rate and commitment to terminal differentiation of subpopulations of mutine keratinocytes, Cell 32: 247–255.PubMedCrossRefGoogle Scholar
  110. 110.
    Yuspa, S. H., Morgan, D., Lichti, U., Spangler, E. F., Michael, D., Kilkenny, A., and Hennings, H., 1986, Cultivation and characterization of cells derived from mouse skin papillomas induced by an initiation—promotion protocol, Carcinogenesis 7: 949–958.PubMedCrossRefGoogle Scholar
  111. 111.
    Kulesz-Martin, M., Kilkenny, A. E., Holbrook, K. A., Digernes, V., and Yuspa, S. H., 1983, Properties of carcinogen altered mouse epidermal cells resistant to calcium-induced terminal differentiation, Carcinogenesis 4: 1367–1377.PubMedCrossRefGoogle Scholar
  112. 112.
    Colburn, N. H., Vorder Bruegge, W. F., Bates, J. R., Gray, R. H., Rossen, J. D., Kelsey, W. H., and Shimada, T., 1978, Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells, Cancer Res. 38: 624–634.PubMedGoogle Scholar
  113. 113.
    Colbum, N. H., 1980, Tumor promoter produces anchorage independence in mouse epidermal cells by an induction mechanism, Carcinogenesis 1: 951–954.CrossRefGoogle Scholar
  114. 114.
    Lerman, M. I., Hegamyer, G. A., and Colbum, N. H., 1986, Cloning and characterization of putative genes that specify sensitivity to neoplastic transformation by tumor promoters, Int. J. Cancer 37: 293–302.Google Scholar
  115. 115.
    Mawley Nelson, P., Stanley, J., Schmidt, J., Gullino, M., and Yuspa, S. H., 1982, The tumor promoter 12-O-tetradecanoylphorbol-13-acetate accelerates keratinocyte differentiation and stimulates growth of an identified cell type in cultured human epidermis, Exp. Cell Res. 137: 117–155.Google Scholar
  116. 116.
    Chida, K., and Kuroki, T., 1984, Inhibition of DNA synthesis and sugar uptake and lack of induction of omithine decarboxylase in human epidermal cells treated with mouse skin tumor promoters, Cancer Res. 44: 875–879.PubMedGoogle Scholar
  117. 117.
    Willey, J. C., Moser, C. E., Jr., Lechner, J. F., and Harris, C. C., 1984, Differential effects of 12–0tetradecanoylphorbol-13-acetate on cultured normal and neoplastic human bronchial epithelial cells, Cancer Res. 44: 5124–5126.PubMedGoogle Scholar
  118. 118.
    Friedman, E. A., 1981, Differential response of premalignant epithelial cell classes to phorbol ester tumor promoters and to deoxycholic acid, Cancer Res. 41: 4588–4599.PubMedGoogle Scholar
  119. 119.
    Sasajima, K., Willey, J. C., Banks-Schlegel, S. P., and Harris, C. C., 1987, Effects of tumor promoters and cocarcinogens on growth and differentiation of cultured human esophageal epithelial cells, J. Natl. Cancer Inst. 78: 419–423.PubMedGoogle Scholar
  120. 120.
    Trosko, J. E., and Chang, C. C., 1984, Role of intercellular communication in tumor promotion, in: Mechanisms of Tumor Promotion, Vol. IV: Cellular Responses to Tumor Promoters ( T. J. Slage, ed.), pp. 119–145, CRC Press, Boca Raton, Florida.Google Scholar
  121. 121.
    Trosko, J. E., 1987, Mechanisms of tumor promotion. Possible role of inhibited intercellular communication, Eur. J. Cancer Clin. Oncol. 23: 599–601.PubMedCrossRefGoogle Scholar
  122. 122.
    Murray, A. W., and Fitzgerald, D. J., 1979, Tumor promoters inhibit metabolic cooperation in co-cultures of epidermal and 3T3 cells, Biochem. Biophys. Res. Commun. 91: 395–401.PubMedCrossRefGoogle Scholar
  123. 123.
    Yotti, L. P., Chang, C. C., and Trosko, J. E., 1979, Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter, Science 206: 1089–1091.PubMedCrossRefGoogle Scholar
  124. 124.
    Trosko, J. E., Yotti, L. P., Warren, S. T., Tsushimoto, G., and Chang, C. C., 1982, Inhibition of cell-cell communication by tumor promoters, in: Carcinogenesis: A Comprehensive Survey, Vol. 7: Cocarcinogenesis and Biological Effects of Tumor Promoters ( E. Hecker, N. E. Fusenig, W. Kunz, F. Marks, and H. W. Thielmann, eds.), pp. 565–585, Raven, New York.Google Scholar
  125. 125.
    Walder, L., and Lutzelschwab, R., 1984, Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA), retinoic acid and diazepam on intercellular communication in a monolayer of rat liver epithelial cells, Exp. Cell Res. 152: 66–76.PubMedCrossRefGoogle Scholar
  126. 126.
    Radner, B. S., and Kennedy, A. R., 1984, Effects of agents known to antagonize the enhancement of in vitro transformation by 12-tetradecanoylphorbol-13-acetate (TPA) on the TPA suppression of metabolic cooperation, Cancer Lett. 25: 139–144.PubMedCrossRefGoogle Scholar
  127. 127.
    Davidson, J. S., Baumgarten, I. M., and Harley, E. H., 1985, Effects of 12-O-tetradecanoylphorbol-l3acetate and retinoids on intercellular junctional communication measured with a citrulline incorporation assay, Carcinogenesis 6: 645–650.PubMedCrossRefGoogle Scholar
  128. 128.
    Tsuda, H., and Okamoto, H., 1986, Elimination of metabolic cooperation by glycyrrhetinic acid, an antitumor promoter, in cultured Chinese hamster cells, Carcinogenesis 7: 1805–1807.PubMedCrossRefGoogle Scholar
  129. 129.
    Blumberg, P. M., 1981, In vitro studies on the mode of action of the phorbol esters, potent tumor promoters: Parts 1 and 2, CRC Critical Rev. Toxicol. 8: 153–234.CrossRefGoogle Scholar
  130. 130.
    Kraft, A. S., and Andess, W. B., 1983, Phorbol esters increase the amount of CA2+, phospholipiddependent protein kinase associated with plasma membrane, Nature (Lond.) 301: 621–623.CrossRefGoogle Scholar
  131. 131.
    Nishizuka, Y., 1986, Perspectives on the role of protein kinase C in stimulus-response coupling, J. Natl. Cancer Inst. 76: 363–370.PubMedGoogle Scholar
  132. 132.
    Housey, G. M., O’Brian, C. A., Johnson, M. D., Kirschmeier, P., and Weinstein, I. B., 1987, Isolation of cDNA clones encoding protein kinase C: Evidence for a protein kinase C-related gene family, Proc. Natl. Acad. Sci. USA 84: 1065–1069.PubMedCrossRefGoogle Scholar
  133. 133.
    Dreidger, P. E., and Blumberg, P. M., 1980, Specific binding of phorbol ester tumor promoters, Proc. Natl. Acad. Sci. USA 77: 571–567.Google Scholar
  134. 134.
    Horowitz, A., Greenebaum, E., and Weinstein, I. B., 1981, Identification of receptors for phorbol ester tumor promoters in intact mammalian cells and of an inhibitor of receptor binding in biologic fluids, Proc. Natl. Acad. Sci. USA 78: 2315–2319.PubMedCrossRefGoogle Scholar
  135. 135.
    Bishop, J. M., 1985, Viral oncogenes, Cell 42: 23–38.PubMedCrossRefGoogle Scholar
  136. 136.
    Vande Woude, G. F., Levine, A. J., Topp, W. C., and Watson, J. D. (eds.), 1984, The Cancer Cell, Vol. II: Oncogenes and Viral Genes, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.Google Scholar
  137. 137.
    Weinstein, I. B., 1987, Growth factors, oncogenes, and multistage carcinogenesis, J. Cell Biochem. 33: 213–224.PubMedCrossRefGoogle Scholar
  138. 138.
    Cambier, J. C., Newell, M. K., Justeman, L. B., McGuire, J. C., Leach, K. L., and Chen, Z. Z., 1987, Ia binding ligands and cAMP stimulate nuclear translocation of PKC in f3 lymphocytes, Nature (Lond.) 327: 629–632.CrossRefGoogle Scholar
  139. 139.
    DePaoli-Roach, A., Roach, P. J., Zucker, K. E., and Smith, S. S., 1986, Selective phosphorylation of human DNA methyltransferase by protein kinase C, FEBS Lett. 197: 149–153.PubMedCrossRefGoogle Scholar
  140. 140.
    Singh, N., Leduc, Y., Poirier, G., and Cerutti, P., 1985, Non-histone chromosomal protein acceptors for poly(ADP)-ribose in phorbol-12-myristate-13-acetate treated mouse embryo fibroblasts (C3H10T1/2), Carcinogenesis 6: 1489–1494.PubMedCrossRefGoogle Scholar
  141. 141.
    Williams, G. M., and Furuya, K., 1984, Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide, Carcinogenesis 5: 171 - -174.PubMedCrossRefGoogle Scholar
  142. 142.
    Chauhan, V. P. S., and Brockerhoff, H., 1987, Phenobarbital competes with diacylglycerol for protein kinase C, Life Sci. 40: 89–93.PubMedCrossRefGoogle Scholar
  143. 143.
    Rovera, G., O’Brien, T. A., and Diamond, L., 1977, Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in cultures, Proc. Natl. Acad. Sci. USA 74: 2894–2898.PubMedCrossRefGoogle Scholar
  144. 144.
    Huberman, E., and Callaham, M. F., 1979, Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents, Proc. Natl. Acad. Sci. USA 76: 1293–1297.PubMedCrossRefGoogle Scholar
  145. 145.
    Ryffel, B., Henning, C. B., and Huberman, E., 1982, Differentiation of human T-lymphoid leukemia cells into cells that have a suppressor phenotype is induced by phorbol 12-myristate 13-acetate, Proc. Natl. Acad. Sci. USA 79: 7336–7340.PubMedCrossRefGoogle Scholar
  146. 146.
    Murao, S., Epstein, A. L., Clevenger, O. V., and Huberman, E., 1985, Expression of maturation-specific nuclear antigens in differentiating human myeloid leukemia cells, Cancer Res. 45: 791–795.PubMedGoogle Scholar
  147. 147.
    Kiguchi, K., Henning-Chubb, C., and Huberman, E., Alteration in glycosphingolipid pattern during phorbol-12-myristate-l3-acetate-induced cell differentiation in human T-lymphoid leukemia cells, Cancer Res. 46: 3027–3033.Google Scholar
  148. 148.
    Homma, Y., Henning-Chubb, C. B., and Huberman, E., 1986, Translocation of protein kinase C in human leukemia cells susceptible or resistant to differentiation induced by phorbol 12-myristate 13-acetate, Proc. Natl. Acad. Sci. USA 83: 7316–7319.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Carl Peraino
    • 1
  • Carol A. Jones
    • 1
  1. 1.Biological, Environmental, and Medical Research DivisionArgonne National LaboratoryArgonneUSA

Personalised recommendations